MétaCan
Menu
← Retour à la cohorte
Enregistrement W2011244541 · doi:10.1177/1715163514530833

New program helps pharmacists give better patient care with lab tests

2014· article· en· W2011244541 sur OpenAlexvenueaboutno aff
Christine D. LeBlanc

Notice bibliographique

RevueCanadian Pharmacists Journal / Revue des Pharmaciens du Canada · 2014
Typearticle
Langueen
DomaineMedicine
ThématiquePharmaceutical Practices and Patient Outcomes
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésPharmacistPharmacyTest (biology)Continuing educationMedical educationNova scotiaMedicineNursingSociology

Résumé

récupéré en direct d'OpenAlex

The Canadian Pharmacists Association (CPhA) introduced a new continuing professional development program in March to train pharmacists in ordering, monitoring and interpreting lab tests. “Lab Tests—Ordering, Monitoring and Interpreting Laboratory Tests to Optimize Medication Management” is a response to some provinces increasing pharmacist authority to order lab tests or access lab results. Interest from the Pharmacists’ Association of Saskatchewan (PAS) first indicated that CPhA was on the right track about 3 years ago. “We were getting signals that pharmacists were going to get the authority. We wanted to meet the demand when the changes happened,” says Phil Emberley, Director, Pharmacy Innovation. PAS was the leader in the creation of the new program (known as Lab Tests), Emberley says. “Given the other work we do with continuing professional development, they thought we could take this on.” CPhA started by working with the University of Waterloo to tailor a course it offered to meet the needs of practising pharmacists. Lab Tests was reviewed by practising pharmacists and academics to make sure the content was accurate and appropriate for pharmacists. Emberley is also going to take the program himself. “It’s really meeting a need,” he says. Currently pharmacists have more authority in Alberta, Manitoba, New Brunswick and Nova Scotia, while other provinces are considering it to various degrees. “When you have access to lab test results, there’s a professional responsibility implied that you’ll know how to use them to improve the care of patients,” Emberley says. The new program is the solution for pharmacists who have access to lab values but aren’t confident in knowing how to use them. Pharmacists having access to lab values and the skills to interpret them will benefit their patients and other health care providers, as well as pharmacists themselves, says Jennifer Gibson, a hospital-based pharmacist in Winnipeg, Manitoba. Patients will benefit from having all their health care providers able to evaluate their care appropriately, while physicians will have more support from and confidence in pharmacists. Time will be saved from streamlined communications between prescriber and pharmacist once both have the same patient information, Gibson explains. She works with kidney transplant recipients and says lab values are completely integrated into everything she does. Hospital pharmacists already have access to lab values, and she sees the authority continuing to spread with expanded scope and legislation changing across the country. Gibson is also a moderator for CPhA’s ADAPT patient care skills development program, which has a lab values component that provides some basic information on common tests. A recent conversation between moderators and students highlighted the difference in authority between provinces and the need for a program like Lab Tests to give pharmacists a better understanding of lab values. Maryann Chmilar, another ADAPT moderator, is a hospital-based pharmacist in Alberta, where pharmacists have to register with their provincial association before they can order and access lab values. “Along with the privilege and efficiency comes increased responsibility for patient care,” she says. “There’s a responsibility to look at the results and come up with care recommendations. The responsibility is all the way through.” For almost every condition and most medications there is a relevant lab value that will tell you the status of the condition and the effects or side effects of the drug, Chmilar says. Knowing how to monitor and interpret lab values is key to assessing care and knowing whether adjustments are required. “You can’t fix what you don’t know about,” she says. She plans on taking the Lab Tests program as a refresher, adding that online courses are a convenient way to keep up with improvements in care. The 12.75 CEU online module course discusses pharmacist responsibility for lab tests and basic skills in interpretation. Electrolyte, kidney function, liver, endocrine, cholesterol and hematologic tests are covered. Participants can start as soon as they register and can learn at their own pace in their own time. ■

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,007
score de la tête « metaresearch » (Gemma)0,034
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Autre · Signal consensuel: Autre
Score de désaccord entre enseignants0,091
Score d'incertitude au seuil0,304

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0070,034
Méta-épidémiologie (sens strict)0,0010,001
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0020,001
Études des sciences et des technologies0,0030,001
Communication savante0,0060,007
Science ouverte0,0020,005
Intégrité de la recherche0,0030,005
Charge utile insuffisante (le modèle a refusé de juger)0,0910,040

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,045
Tête enseignante GPT0,321
Écart entre enseignants0,276 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreAutre

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2014
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueCanadian Pharmacists Journal / Revue des Pharmaciens du Canada→Même sujetPharmaceutical Practices and Patient Outcomes→Travaux en français237 207→